USPTO serial 79107537
NANOXRAY
Reviewed by CopyMark Law Group
Reg. 4248033Status 709
- Filing date
- Status date
- Registration date
- Nov 27, 2012
- Examiner
- MURRAY, DAVID T
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NANOXRAY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
F-75012 Paris, FR
F-75012 Paris, FR
Paris, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James R Menker
James R Menker Holley & Menker, PAPO Box 331937Atlantic Beach, FL 32233UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Preparations for medical use particularly for the diagnosis and treatment of tumors; preparations for medical use particularly for the diagnosis and treatment of tumors using radiation treatment; radioactive substances for medical use for the diagnosis and treatment of tumors using radiation treatment; radiological contrast substances for medical use; chemical reagents for medical use; bacteriological preparations for medical use; enzymes for medical use; enzyme preparations for medical use; diagnostic preparations for medical use; antibiotics; antiseptics; health care preparations for treating cancer; biological preparations for medical use for the treatment of cancer; chemical preparations for medical or pharmaceutical use particularly for use in treating cancer; drugs for medical use for use in the treatment of cancer; medicines for human purposes for use in the treatment of cancer; restorative medicine for use in the treatment of oncological diseases; chemical-pharmaceutical preparations for use in treating oncological disease and disorders; pharmaceutical preparations for use in treating oncological disease and disorders | SECTION 71 - CANCELLED | — |
| 010 | Apparatus for use in medical analysis, namely, medical X-ray apparatus, diagnostic apparatus for medical use, namely, medical X-ray apparatus; radiology screens for medical use; X-ray photographs for medical purposes; medical X-ray apparatus and installations, namely, mounts for the production of X-rays, for medical use; X-ray protection devices for medical use, namely, radiology screens; special furniture for medical use, namely, therapeutic mattresses, beds, seats and cushions | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely, research and design services in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications for use in nanomedicine which is nanotechnology applied to medicine; scientific and technological evaluations, estimates and investigations provided by engineers, researchers in the field of nanomedicine; technical project studies, namely, technical research in the field of nanomedicine; industrial analysis and research services in the field of nanomedicine; chemistry services, namely, chemistry consultation; expert appraisals in the field of engineering, namely, consultation in the field of engineering; technical research in the field of nanomedicine | SECTION 71 - CANCELLED | — |
| 044 | Health services particularly in the field of nanomedicine, namely, use of nanomedicine in disease management programs; medical services particularly in the field of nanomedicine, namely, use of nanomedicine in disease management programs | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nanobiotix
- Other trademarks owned by Nanobiotix
- Other trademarks owned by Nanobiotix
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NANOXRAY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 3, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 9, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 9, 2024 | INPC | INVALIDATION PROCESSED | — |
| Feb 9, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 9, 2023 | C71T | CANCELLED SECTION 71 | — |
| Nov 27, 2021 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Nov 26, 2021 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jul 17, 2019 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jul 17, 2019 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jul 4, 2019 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Jan 17, 2019 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Jan 17, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 27, 2018 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 25, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 6, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 6, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 27, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 27, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 16, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 11, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 22, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 22, 2012 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 22, 2012 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 9, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 9, 2012 | ALIE | ASSIGNED TO LIE | — |
| Jul 27, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 26, 2012 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 26, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 26, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 26, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2012 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 5, 2012 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 5, 2012 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 2, 2012 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 1, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 2012 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Mar 1, 2012 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 29, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 17, 2012 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 13, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 12, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |